Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?
Asianet Newsable on MSN
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal
Shares of Kimberly-Clark Corp. declined 0.3% in early premarket trading on Tuesday, after Monday’s steep drop triggered by ...
Kimberly-Clark Corporation, the parent company behind Kleenex and Huggies, has unveiled plans to acquire consumer health firm Kenvue in a cash-and-stock deal valued at about US$48.7 billion.
22mon MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Asian shares are trading mixed after overseas markets got a big lift from optimism over AI technology. Shares rose in Hong ...
Dow Jones Top Company Headlines at 5 AM ET: Saudi Aramco's Net Profit Rises on Higher Production, Oil Prices | BP ... Third-quarter profit rose compared with the prior three-month period but declined ...
The S&P 500 rose 0.2% and pulled closer to its all-time high set last week, even though the majority of stocks in the index ...
The latest investor updates on stocks that are trending on Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results